F |
Clinical Pharmacology in Adults |
Studies of pharmacokinetics and pharmacodynamics (PK/PD) of small and large molecule drugs in animal models and adult humans, including drug absorption, distribution, metabolism, and excretion, novel dosing regimens, drug interactions, simulation and modeling, and novel uses of objective drug adherence and exposure metrics.
Studies of infants, children, or adolescents should be submitted to category (P). |
G |
Antiviral Therapy: Pre-Clinical Data, Randomized Trials, Efficacy, and Effectiveness Studies in HIV or SARS-CoV-2 or Mpox Virus in Adults |
Studies of antiviral agents and combinations, including virus-directed monoclonal antibodies and new antiviral agents (including pre-clinical data, interventional trials, and observational and cohort studies) where the focus is on antiviral therapy and antiviral treatment strategies for HIV or SARS-CoV-2 or mpox virus. Studies of patient and provider attitudes about different antiviral treatment options and studies of adherence should be submitted here.
Studies that focus on resistance should be submitted to category (H). |
H |
Resistance of HIV or SARS-CoV-2 to Small Molecules and Antibodies in Adults |
Studies of molecular mechanisms, pathogenesis, clinical implications, epidemiology, and diagnostics around resistance.
Studies of infants, children, or adolescents should be submitted to category (P). |
I |
Hepatitis Viruses and Liver Complications in Adults |
Studies of diagnostics, epidemiology, pathogenesis, and therapy for hepatitis viruses and liver complications of HIV or SARS-CoV-2 in adults.
Studies of infants, children, or adolescents should be submitted to category (P). |
J |
HIV-Related Malignancies and Tumor Viruses |
Studies of epidemiology, pathobiology, prognostic biomarkers, incidence, treatment, gynecologic malignancies, human papillomavirus screening, and prevention approaches for malignancies or premalignant lesions in patients with HIV infection. |
K |
Cardiovascular Complications of HIV Infection and Antiretroviral Therapy |
Complications of HIV infection and antiretroviral therapy including coronary and cardiac complications, lipids, and peripheral vascular atheromatous disease.
Cerebrovascular complications, including stroke, should be submitted to category (E). |
L |
Other Complications of HIV Infection and Antiretroviral Therapy in Adults |
Studies of renal, bone, frailty, metabolic, and other complications (excluding neurologic or liver complications) in HIV. Neurologic complications should be submitted to category (E). Liver complications should be submitted to category (I). |
M |
Clinical Manifestations and Outcomes of SARS-CoV-2, Including Long COVID, and Mpox Infections |
Studies of clinical manifestations and co-morbidities associated with, and complications of, SARS-CoV-2 and mpox in adults. Includes acute COVID-19 disease and post-acute sequelae of COVID-19 (PASC, or long COVID).
Neurologic complications of COVID-19 should be submitted to category (E). Studies of infants, children, or adolescents should be submitted to the categories (O) or (P). |
N |
Tuberculosis and Other Opportunistic Infections, Including the Impact of HIV or SARS-CoV-2 in Adults |
Basic and clinical studies of bacterial, fungal, parasitic, mycobacterial, and non-hepatitis viral infections, including the impact of coinfections with SARS-CoV-2, tuberculosis, and other opportunistic infections. This category will also include integrated strategy studies that evaluate the effectiveness, safety, and acceptability of biomedical, behavioral, and structural interventions to treat or prevent coinfections and opportunistic infections in people with HIV. |
O |
Maternal and Fetal HIV, SARS-CoV-2, and Mpox Virus |
Studies of maternal-fetal HIV, SARS-CoV-2, mpox, and their related infections: transmission, prevention, treatment, pregnancy, and postpartum maternal health. Includes: Mother-to-child transmission; approaches to diagnosis, prevention, and treatment of infections and co-morbidities during pregnancy and breastfeeding; possible risks associated with treatments in pregnancy and breastfeeding; issues of postpartum maternal health; and early infant diagnosis. |
P |
Childhood and Adolescent HIV, SARS-CoV-2, or Mpox Virus |
Studies of the diagnosis, treatment, and management (including biomedical, behavioral, and structural interventions) of HIV and related co-infections and co-morbidities in infants, children, and young adults, including HIV-exposed uninfected infants and children. This category includes SARS-CoV-2 and mpox in these populations. |